Sequenom v. Ariosa: What the PTO Should Do; and Why The Patent Office should revise its procedures to mandatorily examine any case with a patent-eligibility issue under 35 USC § ...
In Sequenom v. Ariosa, Eli Lilly, Eisai, Upsher-Smith, Pfizer and Etiometry as joint amici have boldly abandoned petitioner’s Question Presented. Reprising the unsuccessful argument made by the Government in Mayo, ...
E-mail subscriptions to the TTABlog are available. Just enter your e-mail address in the box on the right to receive a daily update via Feedblitz. You may also follow the ...
In ClearCorrect Operating, LLC v. Int'l Trade Comm'n, __ F.3d __, __ (Fed. Cir. Nov. 10, 2015)(Prost, J.), reh’g en banc denied, __ F.3d __ (Fed. Cir. March 31, 2016), ...
The Trademark Trial and Appeal Board has scheduled ten (10) oral hearings for the month of April. The first five (5) were listed yesterday. The next five (5) are listed ...
This Friday the Court is scheduled to consider grant of certiorari in Retirement Capital Access Management Co. LLC v. U.S. Bancorp, No. 15-591, where the firstQuestion Presented asks “[w]hether subject ...
The Trademark Trial and Appeal Board has scheduled ten (10) oral hearings for the month of April, as listed below. Here are the first five (5). All of the hearings ...
The Board affirmed two refusals to register the mark EMDROPS for "dietary and nutritional supplements in liquid form which do not include effective microorganisms or efficient microbes," finding the mark ...
The next Top Ten Patent Cases will list as No. (5) “Limelight II”, Limelight Networks, Inc. v. Akamai Technologies, Inc., S. Ct. No. 15-993, opinion below, Akamai Techs., Inc. v. Limelight Networks, Inc., ...
Ruling that the marks IMÁGENES ESCONDIDAS and HIDDEN PICTURES are not "the same mark" for Section 2(f) purposes, the Board affirmed a Section 2(e)(1) mere descriptiveness refusal to register the ...